Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Prof. Dr. Christof Von Kalle National Center for Tumor Diseases and German Cancer Research Center, Germany1 Talk
Professor Christof von Kalle has been director of the Department of Translational Oncology at NCT and DKFZ since July 2005, chairing the NCT Board of Directors. As a physician scientist, with a clinical background in hematology/oncology, Prof. von Kalle is an internationally renowned scientific leader in stem‐cell research, mutation analysis,... read moreand gene transfer, with >150 high‐impact publications. He is an elected member of the European Academy of Cancer Sciences and serves as chair of the CCC Network of German Cancer Aid. Prof. von Kalle coordinates overall NCT activities, with the primary goal of facilitating excellence in translational and clinical research. The department is home to internationally renowned research groups for stem‐cell research, applied functional genomics, lymphoma research, molecular diagnostics, and gene therapy. Physician scientists are involved in clinical activities, patient care and innovative clinical trials. The department oversees NCT POP, providing individual patient treatment based on in‐depth molecular analysis.